• 1
    Blake GJ, Ridker PM. CRP and other inflammatory markers in acute coronary syndromes. J Am Coll Cardiol 2003; 41: 375425.
  • 2
    Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, Zeiher A, Chaitman BR, Leslie S, Stern T. Effect of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. J Am Med Assoc 2001; 285: 17118.
  • 3
    Jialal I, Stein D, Balis D, Grundy SM, Adams Heut B, Devaraj S. Effect of HMG-CoA reductase inhibitor therapy on high sensitivity CRP levels. Circulation 2001; 103: 19335.
  • 4
    Patel TN, Shishehbor MH, Bhatt DL. A review of high-dose statin therapy: targeting cholesterol and inflammation in atherosclerosis. Eur Heart J 2007; 28: 66472.
  • 5
    Papathanasiou AI, Pappas KD, Korantzopoulus P, Leontaridis JP, Vougiouklakis TG, Kiriou M, Dimitroula V, Michalis LK, Goudevenos JA. An epidemiological study of acute coronary syndromes in north western Greece. Angiology 2004; 55: 18794.
  • 6
    Deshpande NV, Mardiker HM, Khan A, Mahorkar U, Fulwani M, Mardikar M. Effect of statin therapy on C-reactive protein in patients with acute coronary syndromes (Abstract). Indian Heart J 2003; 55: 463.
  • 7
    Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin and risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 9739.
  • 8
    Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an ACE-inhibitor, ramipril on cardiovascular events in high risk patients. The heart outcome prevention evaluation study investigators. N Engl J Med 2000; 342: 14553.
  • 9
    Ridker PM. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial. Circulation 2003; 108: 22927.
  • 10
    Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, Pfeffer MA, Braunwald E. C-reactive protein levels and outcome after statin therapy. N Engl J Med 2005; 352: 208.